(thirdQuint)Efficacy Study of Condrosulf in the Treatment of Symptomatic OA of the Hand.

 The goal of the present study is to investigate the effectiveness of Condrosulf(R) 800 mg tablets vs.

 placebo once a day for 6 months in the symptomatic treatment of finger joint osteoarthritis in 160 randomised patients.

 Primary endpoints: Primary endpoints of the study are the evaluation of global spontaneous pain (Huskisson's Visual Analogue Scale: VAS) and the score of Dreiser's algo-functional index (FIHOA) during the treatment with the tested product, Condrosulf(R), versus placebo.

 Secondary endpoints are: Efficacy evaluation: Global impression of efficacy expressed by the patient and the physician (VAS), Grip strength (measured manometrically); Morning stiffness duration; Consumption of Paracetamol; Tolerability (4-point verbal scale); Adverse Events occurring during the treatment period; Other parameters:Treatment compliance; Biological markers of arthritis.

 Efficacy Study of Condrosulf in the Treatment of Symptomatic OA of the Hand@highlight

The goal of the present study is to investigate the effectiveness of Condrosulf(R) 800 mg tablets vs.

 placebo once a day for 6 months in the symptomatic treatment of finger joint osteoarthritis.

 Primary endpoints of the study are the evaluation of global spontaneous pain (Huskisson's Visual Analogue Scale: VAS) and the score of Dreiser's algo-functional index (FIHOA) during the treatment with the tested product, Condrosulf(R), versus placebo.

